Víctor Farricha

427 total citations
8 papers, 290 citations indexed

About

Víctor Farricha is a scholar working on Oncology, Biotechnology and Biomedical Engineering. According to data from OpenAlex, Víctor Farricha has authored 8 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Biotechnology and 4 papers in Biomedical Engineering. Recurrent topics in Víctor Farricha's work include Microbial Inactivation Methods (4 papers), Cutaneous Melanoma Detection and Management (3 papers) and Microfluidic and Bio-sensing Technologies (2 papers). Víctor Farricha is often cited by papers focused on Microbial Inactivation Methods (4 papers), Cutaneous Melanoma Detection and Management (3 papers) and Microfluidic and Bio-sensing Technologies (2 papers). Víctor Farricha collaborates with scholars based in Portugal, Italy and France. Víctor Farricha's co-authors include A. James P. Clover, Gregor Serša, Tobian Muir, Antonio Occhini, Joy Odili, Christian Kunte, Declan M. Soden, Giulia Bertino, Louise Wichmann Matthiessen and L Campana and has published in prestigious journals such as Frontiers in Oncology, Acta Oncologica and International Journal of Dermatology.

In The Last Decade

Víctor Farricha

6 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Víctor Farricha Portugal 4 232 117 70 51 41 8 290
Joy Odili United Kingdom 9 358 1.5× 157 1.3× 126 1.8× 95 1.9× 77 1.9× 17 471
Roberta Rotunno Italy 11 263 1.1× 91 0.8× 123 1.8× 85 1.7× 70 1.7× 33 431
Louise Wichmann Matthiessen Denmark 7 467 2.0× 219 1.9× 184 2.6× 80 1.6× 89 2.2× 9 559
Rebecca M. Brock United States 11 286 1.2× 198 1.7× 121 1.7× 77 1.5× 99 2.4× 19 477
Tanja Blagus Slovenia 11 192 0.8× 107 0.9× 64 0.9× 19 0.4× 111 2.7× 31 380
Natalie Beitel-White United States 11 333 1.4× 236 2.0× 89 1.3× 68 1.3× 72 1.8× 15 465
Matteo Brizio Italy 8 62 0.3× 23 0.2× 46 0.7× 60 1.2× 36 0.9× 18 155
Brian Athos United States 6 366 1.6× 233 2.0× 82 1.2× 18 0.4× 76 1.9× 7 413
Mark Kreis United States 6 366 1.6× 233 2.0× 82 1.2× 18 0.4× 76 1.9× 7 413
Denis Pavliha Slovenia 9 462 2.0× 354 3.0× 105 1.5× 25 0.5× 54 1.3× 9 540

Countries citing papers authored by Víctor Farricha

Since Specialization
Citations

This map shows the geographic impact of Víctor Farricha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Víctor Farricha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Víctor Farricha more than expected).

Fields of papers citing papers by Víctor Farricha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Víctor Farricha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Víctor Farricha. The network helps show where Víctor Farricha may publish in the future.

Co-authorship network of co-authors of Víctor Farricha

This figure shows the co-authorship network connecting the top 25 collaborators of Víctor Farricha. A scholar is included among the top collaborators of Víctor Farricha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Víctor Farricha. Víctor Farricha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Roque, Lúcia, Ana Luísa Silva, Hugo Nunes, et al.. (2025). A novel patient-derived cutaneous melanoma cell line reveals key features of metastatic melanoma. Frontiers in Oncology. 15. 1531013–1531013.
2.
Farricha, Víctor, et al.. (2025). Melanoma Diagnosis With 3D Total-Body Photography. Actas Dermo-Sifiliográficas. 116(10). 1116–1122. 1 indexed citations
3.
Farricha, Víctor, et al.. (2025). [Artículo traducido] Diagnóstico de melanoma con fotografía corporal total en 3D. Actas Dermo-Sifiliográficas. 116(10). T1116–T1122.
4.
Farricha, Víctor, et al.. (2022). Cutaneous and subcutaneous Kaposi's sarcoma lesions treated with electrochemotherapy. International Journal of Dermatology. 62(1). 115–119. 5 indexed citations
5.
Farricha, Víctor, et al.. (2020). Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Dermatologic Therapy. 33(6). e14093–e14093. 4 indexed citations
6.
Farricha, Víctor, Pietro Quaglino, Matteo Brizio, et al.. (2020). Safety and efficacy of electrochemotherapy in a series of patients with nonmetastasized primary or recurrent anorectal malignant melanoma. Melanoma Research. 31(1). 76–80. 3 indexed citations
7.
Gehl, Julie, Gregor Serša, Louise Wichmann Matthiessen, et al.. (2018). Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncologica. 57(7). 874–882. 269 indexed citations
8.
Farricha, Víctor, et al.. (2008). Merkel cell carcinoma: An unusual indication for isolated limb perfusion. Dermatology Online Journal. 14(7). 6–6. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026